These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3568537)

  • 1. Studies on theophylline metabolism: autoinduction and inhibition by antipyrine.
    Denlinger CL; Stryker KK; Slusher LB; Vesell ES
    Clin Pharmacol Ther; 1987 May; 41(5):522-30. PubMed ID: 3568537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cimetidine impairs the elimination of theophylline and antipyrine.
    Roberts RK; Grice J; Wood L; Petroff V; McGuffie C
    Gastroenterology; 1981 Jul; 81(1):19-21. PubMed ID: 7239117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
    Teunissen MW; De Leede LG; Boeijinga JK; Breimer DD
    J Pharmacol Exp Ther; 1985 Jun; 233(3):770-5. PubMed ID: 4009489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of the effect of antipyrine on caffeine kinetics in six healthy volunteer subjects.
    Soto J; Alsar MJ
    J Clin Pharm Ther; 1997 Jun; 22(3):191-5. PubMed ID: 9447474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
    Groen K; Breimer DD; van Bezooijen CF
    Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of antipyrine and theophylline metabolism in man: molecular and clinical implications.
    Vesell ES
    Xenobiotica; 1986 May; 16(5):401-20. PubMed ID: 3739366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of charcoal-broiled beef on antipyrine and theophylline metabolism.
    Kappas A; Alvares AP; Anderson KE; Pantuck EJ; Pantuck CB; Chang R; Conney AH
    Clin Pharmacol Ther; 1978 Apr; 23(4):445-50. PubMed ID: 630792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diltiazem treatment impairs hepatic drug oxidation: studies of antipyrine.
    Carrum G; Egan JM; Abernethy DR
    Clin Pharmacol Ther; 1986 Aug; 40(2):140-3. PubMed ID: 3731677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between antipyrine and aminopyrine.
    Vesell ES; Passananti GT; Hepner GW
    Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
    Abernethy DR; Egan JM; Dickinson TH; Carrum G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism.
    Dahlqvist R; Bertilsson L; Birkett DJ; Eichelbaum M; Säwe J; Sjöqvist F
    Clin Pharmacol Ther; 1984 Jun; 35(6):815-21. PubMed ID: 6734034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer.
    Lønning E; Kvinnsland S; Bakke OM
    Clin Pharmacol Ther; 1984 Dec; 36(6):796-802. PubMed ID: 6499359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrine metabolism during the menstrual cycle.
    Riester EF; Pantuck EJ; Pantuck CB; Passananti GT; Vesell ES; Conney AH
    Clin Pharmacol Ther; 1980 Sep; 28(3):384-91. PubMed ID: 7408398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large theophylline requirements due to high theophylline clearance: verification by the antipyrine test.
    Blyden GT; LeDuc BW; Greenblatt DJ
    Pharmacology; 1986; 32(4):226-31. PubMed ID: 3714804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous results of studies on drug interaction in man. III. Disulfiram and antipyrine.
    Vesell ES; Passananti T; Glenwright PA
    Pharmacology; 1975; 13(6):481-91. PubMed ID: 1221431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH; Back DJ; Breckenridge AM; Howells RE
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
    Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
    Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unaltered metabolism of antipyrine and tolbutamide in fasting man.
    Reidenberg MM; Vesell ES
    Clin Pharmacol Ther; 1975 Jun; 17(6):650-6. PubMed ID: 1139856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.
    Kappas A; Anderson KE; Conney AH; Alvares AP
    Clin Pharmacol Ther; 1976 Dec; 20(6):643-53. PubMed ID: 991535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of antipyrine clearance in humans by propranolol.
    Greenblatt DJ; Franke K; Huffman DH
    Circulation; 1978 Jun; 57(6):1161-64. PubMed ID: 639239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.